Entity
Company
Location
1954 Greenspring Drive, Suite 600, Timonium, MD
Signature
/s/ Louis Citron, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Growth Equity Opportunities Fund IV, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVEO PHARMACEUTICALS, INC. 10%+ Owner Common Stock 0 $15.00 Oct 19, 2022 Direct

Insider Reports Filed by Growth Equity Opportunities Fund IV, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVEO AVEO PHARMACEUTICALS, INC. Oct 19, 2022 1 $0 4 Oct 21, 2022 10%+ Owner